Today we are pleased to welcome Fize Medical to the Nolqa portfolio. We invested $620K to support the company as it builds its next stage of growth.
What Fize Medical does
FIZE Medical develops technology for real-time urine output monitoring and smart fluid management. Its platform is designed to provide clinicians with timely clinical intelligence that can support earlier intervention and more proactive patient treatment.
Why we invested
We invested because fluid management is a critical clinical problem where better data can directly improve decision-making. FIZE combines medical technology, real-time monitoring and AI-powered intelligence around a specific workflow with significant consequences for patient care.
What comes next
We look forward to supporting FIZE as it advances its technology, regulatory progress and adoption across critical-care environments.
We are looking forward to working closely with the team and helping Fize Medical build the next chapter of the business.